Clene Reports Topline Results For CNM-Au8 In Healey ALS Platform Trial
3/10 14:56
(RTTNews) - Clene Inc. (CLNN) and its wholly owned subsidiary biopharmaceutical company Clene Nanomedicine Inc., announced Monday topline study results showing a survival benefit in the Healey ALS Platform trial of CNM-Au8, an investigational gold nanocrystal suspension, in parti...